US 7524880
Crystalline form of a substituted pyrrolidine compound
granted A61PA61P11/06A61P11/08
Quick answer
US patent 7524880 (Crystalline form of a substituted pyrrolidine compound) held by Theravance, Inc. expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P11/06, A61P11/08